Intervention for cannabis use in young people at ultra high risk for psychosis and in early psychosis

Mental Health and Substance Use: Dual Diagnosis

Volumn 3, Issue 1, 2010, Pages 66-73

  Bucci, Sandra ^a   Baker, Amanda ^b   Halpin, Sean A ^c   Hides, Leanne ^d   Lewin, Terry J ^b   Carr, Vaughan J ^e,f   Startup, Mike ^g  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Hunter New England Mental Health   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

'at risk'; Cannabis abuse; Cognitive behaviour therapy; Early intervention; Mental state; Psychosis

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANNABIS ADDICTION; CHILD; COGNITIVE THERAPY; DRUG USE; DRUG USE SCALE OF THE OPIATE TREATMENT INDEX; EARLY INTERVENTION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MENTAL HEALTH SERVICE; MOTIVATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM;

EID: 77951237946     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523280903523983     Document Type: Article

References (35)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders IV. Washington, DC: American Psychiatric Association.
2. Australian Institute of Health and Welfare. (2005). 2004 National Drug Strategy household survey: First results. Canberra: AIHW.
3. Baker, A., Bucci, S., & Kay-Lambkin, F. (2004). Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre.
4. Barnett, J.H., Werners, U., Secher, S.M., Hill, K.E., Brazil, R., Masson, K., et al. (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry, 190, 515-520. (Pubitemid 46868836)
5. Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., et al. (2008). Prediction of psychosis in youth at high clinical risk. Archives of General Psychiatry, 65, 28-37.
6. Carr, V., Halpin, S., Lau, N., O'Brien, S., Beckmann, J., & Lewin, T. (2000). A risk factor screening and assessment protocol for schizophrenia and related psychosis. Australian and New Zealand Journal of Psychiatry, 34, S170-S180.
7. Chambers, W.J., Puig-Antich, J., Hirsch, M., Paez, P., Ambrosini, P.J., Tabrizi, M.A., et al. (1985). The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Archives of General Psychiatry, 42, 696-702. (Pubitemid 15054614)
8. Coldham, E.L., Addington, J., & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286-290. (Pubitemid 35176879)
9. Corcoran, C.M., Kimhy, D., Stanford, A., Khan, S., Walsh, J., Thompson, J., et al. (2008). Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophrenia Research, 106, 286-293.
10. Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addictions, 87, 733-742.
11. Dixon, L. (1999). Dual diagnosis of substance abuse in schizophrenia: Prevalence and impact on outcomes. Schizophrenia Research, 35, 93-100. (Pubitemid 29133030)
12. Edwards, J., Elkins, K., Hinton, M., Harrigan, S.M., Donovan, K., Athanasopoulos, O., et al. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica, 114, 109-117. (Pubitemid 44034269)
13. European Monitoring Centre for Drugs and Drug Addiction. (2005). The state of the drugs problem in Europe: Annual report 2005. Lisbon: EMCDDA.
14. First, M.B., Spitzer, R.L., Miriam, G., & Williams, J.B.W. (Eds.). (2001). Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. New York, NY: Biometrics Research, New York State Psychiatric Institute.
15. Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.U., et al. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11-16. (Pubitemid 40070467)
16. Hides, L., Dawe, S., Kavanagh, D.J., & Young, R.M. (2006). Psychotic symptom and cannabis relapse in recent onset psychosis: Prospective study. British Journal of Psychiatry, 189, 137-143. (Pubitemid 44231272)
17. Kavanagh, D.J., & Mueser, K.T. (2007). Current evidence on integrated treatment for serious mental disorder and substance misuse. Journal of the Norwegian Psychological Association, 44, 618-637.
18. Kavanagh, D.J., Young, R.,White, A., Saunders, J.B.,Wallis, J., Shockley, N., et al. (2004). A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review, 23, 151-155. (Pubitemid 38907018)
19. Kristensen, K., & Cadenhead, K.S. (2007). Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research, 151, 151-154. (Pubitemid 46656299)
20. Lambert, M., Conus, P., Lubman, D.I., Wade, D., Yuen, H., Moritz, S., et al. (2005). The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica, 112, 141-148. (Pubitemid 41003193)
21. Linszen, D.H., Dingemans, P.M., & Lenior, M.E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-279.
22. Miettunen, J., Törmänen, S., Murray, G.K., Jones, P.B., Mäki, P., Ebeling, H., et al. (2008). Association of cannabis use with prodromal symptoms of psychosis in adolescence. British Journal of Psychiatry, 192, 470-471. (Pubitemid 351809902)
23. Moore, T.H.M., Zammit, S., Lingford-Hughes, A., Barnes, T.R.E., Jones, P.B., Burke, M., et al. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet, 370, 319-328. (Pubitemid 47094993)
24. National Survey on Drug Use and Health. (2005). Results from the 2004 National Survey on drug use and health: National findings. Rockville, MD: Substance Abuse and Mental Health Services Administration.
25. Rossler, W., Riecher-Rossler, A., Angst, J., Murray, R., Gamma, A., Eich, D., et al. (2007). Psychotic experiences in the general population: A twenty-year prospective community study. Schizophrenia Research, 92, 1-14. (Pubitemid 46561217)
26. Sembhi, S., & Lee, J.W. (1999). Cannabis use in psychotic patients. Australian and New Zealand Journal of Psychiatry, 33, 529-532. (Pubitemid 29386874)
27. Sorbara, F., Liraud, F., Assens, F., Abalon, F., & Verdoux, H. (2003). Substance use and the course of early psychosis: A 2 year follow-up of first-admitted subjects. European Psychiatry, 18, 133-136. (Pubitemid 36644316)
28. Stefanis, N.C., Delespaul, P., Henquet, C., Bakoula, C., Stefanis, C.N., & Van Os, J. (2004). Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction, 99, 1333-1341. (Pubitemid 39330938)
29. United Nations Office on Drugs and Crime. (2006). World drug report 2006. Volume 1: Analysis. Vienna: United Nations.
30. van Os, J., Bak, M., Hanssen, M., Bijl, R., de Graaf, R., & Verdoux, H. (2002). Cannabis use and psychosis: A longitudinal population based study. American Journal of Epidemiology, 156, 319-327. (Pubitemid 34857999)
31. Verdoux, H., Gindre, C., Sorbora, F., Tournier, M., & Swendsen, J.D. (2003). Effects of cannabis and psychosis vulnerability in daily life: An experience sampling test study. Psychological Medicine, 33, 23-32. (Pubitemid 36113397)
32. Wade, D., Hides, L., Baker, A., & Lubman, D.I. (2008). Substance use and psychosis. In H.J. Jackson & P.D. McGorry (Eds.), The recognition and management of early psychosis: A preventive approach (pp. 243-256). Cambridge: Cambridge University Press.
33. Yung, A.R., Buckby, J.A., Cotton, S.M., Cosgrave, E.M., Killackey, E.J., Stanford, C., et al. (2006). Psychotic-like experiences in nonpsychotic help-seekers: Associations with distress, depression, and disability. Schizophrenia Bulletin, 32, 352-359.
34. Yung, A.R., McGorry, P.D., McFarlane, C.A., Jackson, H.J., Patton, G.C., & Rakkar, A. (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22, 283-303. (Pubitemid 26174575)
35. Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., et al. (2005). Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry, 39, 964-971. (Pubitemid 43904432)